Compare Mesoblast Limited (MESO) vs Under Armour Inc Class A (UA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Mesoblast Limited vs Under Armour Inc Class A — how do they compare? Mesoblast Limited trades at $16.68 (market cap $2.21B), while Under Armour Inc Class A trades at $5.24 (market cap $2.26B). The key difference: Mesoblast Limited and Under Armour Inc Class A are close in size by market cap, and Mesoblast Limited is trading nearer its 52-week high, Under Armour Inc Class A nearer its low. Which is the better fit depends on your goals.
| MESO | UA | |
|---|---|---|
Market Cap | $2.21B | $2.26B |
Sector | Technology | Consumer Cyclical |
52-Week High | $20.96 | $7.88 |
52-Week Low | $12.88 | $3.96 |
Enterprise Value | $2.21B | $3.24B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Mesoblast Limited
Mesoblast Limited is a global leader in allogeneic cellular medicines. The company develops innovative, commercially-ready mesenchymal lineage cell (MLC) technology for the treatment of various inflammatory and cardiovascular conditions. Their pipeline focuses on leveraging the anti-inflammatory, tissue repair, and immune-modulating properties of these cells for diseases with high unmet medical needs, such as acute graft versus host disease (aGVHD) and chronic heart failure.
Read more on MESO →About Under Armour Inc Class A
Under Armour is a leading inventor, marketer, and distributor of branded athletic performance apparel, footwear, and accessories. Built on the 'technical' performance of synthetic fabrics, the company is currently undergoing a multi-year brand evolution centered on premium product innovation, operational rigor, and a renewed focus on its North American core under the guidance of founder Kevin Plank.
Read more on UA →
